• 1
    Dickinson DM, Ellison MD, Webb RL. Data sources and structure. Am J Transplant 2003; 3(Suppl. 4): 1328 .
  • 2
    Wolfe RA, Webb RL, Dickinson DM et al. Analytical approaches for transplant research. Am J Transplant 2003; 3(Suppl. 4): 103113 .
  • 3
    Wolfe, RA, Ashby, VB, Milford, EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 17251730.
  • 4
    Gaston, RS. Evolution of Medicare policy involving transplantation and immunosuppressive medications: past developments and future directions. In: FieldMJ, LawrenceRL, ZwanzigerL, eds. Extending Medicare coverage for preventive and other services. Washington, DC: National Academy Press, 2000: D23D38.
  • 5
    Kasiske BL, Cangro, CB, Hariharan, S et al. The evaluation of renal transplant candidates: clinical practice guidelines. Am J Transplant 2001; 2(Suppl. 1): 595.
  • 6
    Kasiske, B, Ramos, E, Gaston, R et al. The evaluation of renal transplant candidates: clinical practice guidelines. J Am Society Nephrol 1995; 6: 134.
  • 7
    United States Renal Data System (USRDS). 2001 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001.
  • 8
    Schweitzer EJ, Wilson J, Jacobs S et al. Increased rates of donation with laparoscopic donor nephrectomy. Ann Surg 2000; 232: 392400.
  • 9
    Matas AJ, Garvey CA, Jacobs CL, Kahn JP. Nondirected donation of kidneys from living donors. N Engl J Med 2000; 343: 433436.
  • 10
    Deierhoi MH, Barger BO, Hudson SL, Shroyer TW, Diethelm AG. The effect of erythropoietin and blood transfusions on highly sensitized patients on a single cadaver renal allograft waiting list. Transplantation 1992: 53: 363368.
  • 11
    Danovitch GM, Hariharan S, Pirsch JD et al. Management of the waiting list for cadaveric kidney transplants: Report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation. J Am Society Nephrol 2002; 13: 528535.
  • 12
    Wolfe RA, Ojo AO, Ashby VB. Analyses for data request from the Minority Affairs Committee of 4/5/2001. Ann Arbor: Scientific Registry of Transplant Recipients (SRTR), 2001: 10/12/01.
  • 13
    Gaston RS. Addressing minority issues in renal transplantation: is more equitable access an achievable goal? Am J Transplant 2002; 2: 13.
  • 14
    Nelson PW, Shield CF, Muruve NA et al. Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system? Am J Transplant 2002; 2, 9499.
  • 15
    Takemoto SK, Terasaki PI, Gjertson DW, Cecka JM. Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med 2000; 343: 10781084.
  • 16
    Schweitzer EJ, Yoon S, Hart J et al. Increased living donor volunteer rates with a formal recipient family education program. Am J Kidney Diseases 1997; 29: 739745.
  • 17
    Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333336.
  • 18
    Meier-Kriesche H-U, Port FK, Ojo AO et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58: 13111317.
  • 19
    Schaubel D, Desmeules M, Mao Y, Jeffery J, Fenton S. Survival experience among elderly end-stage renal disease patients. A controlled comparison of transplantation and dialysis. Transplantation 1995; 60: 13891394.
  • 20
    Ojo AO, Hanson JA, Meier-Kriesche HU et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Society Nephrol 2001; 12: 589597.
  • 21
    Zenios SA, Wein LM, Chertow GM. Evidence-based organ allocation. Am J Med 1999; 107: 5261.
  • 22
    Cecka JM and The UNOS Scientific Renal Transplant Registry. In: Cecka JM, Terasaki PI, eds. Clinical Transplants 1998. Los Angeles: UCLA Tissue Typing Laboratory, 1999: 116.
  • 23
    Young CJ, Gaston RS. Renal transplantation in black Americans. N Engl J Med 2000; 343: 15451552.
  • 24
    Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy. the concept of accelerated senescence. J Am Society Nephrol 1999; 10: 167181.
  • 25
    Karpinski M, Rush D, Jeffery J et al. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Society Nephrol 2001; 12: 28072814.
  • 26
    Schnitzler MA, Hollenbeak CS, Cohen DS et al. The economic implications of HLA matching in cadaveric renal transplantation. N Engl J Med 1999; 341: 14401446.
  • 27
    Kasiske BL, Ravenscraft M, Ramos E, Gaston RS, Bia MJ, Danovitch GM. The evaluation of living renal transplant donors: clinical practice guidelines. J Am Society Nephrol 1996; 7: 22882313.
  • 28
    Humar A, Ramcharan T, Kandaswamy R et al. Pancreas after kidney transplant. Am J Surg 2001; 182: 155161.
  • 29
    Hariharan S, Pirsch JD, Lu CY et al. Pancreas after kidney transplantation. J Am Society Nephrol 2002; 13: 11091118.
  • 30
    Humar A, Sutherland DER, Ramcharan T, Gruessner RW, Gruessner AC, Kandaswamy R. Optimal timing for a pancreas transplant after kidney transplant. Transplantation 2000; 70: 12471250.
  • 31
    United Network for Organ Sharing. OPTN/UNOS, policy, 3.5. Allocation of cadaveric kidneys. Richmond, VA; UNOS, 2002.